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It is now 11 years since the discovery of EB virus (1), and during that time an im-
mense amount ofinformation has been accumulated on this new human herpes virus
by large numbers ofinvestigators in many different countries (for reviews, see 2-4).
With so many studies currently going forward on this agent and so many new
workers coming into the field, it was thought that a brief historical survey on the
early findings with EB virus might be timely, coupled with a consideration of some
still outstanding problems connected with its biological behavior in man.
DISCOVERY OF EB VIRUS
On March 22, 1961, D. P. Burkitt addressed a combined medical and surgical
staff meeting at the Middlesex Hospital Medical School, London, and presented for
the first time outside Africa an account of epidemiological studies suggesting that
the distribution ofthe highly unusual tumor that now bears his name was connected
with geographical features affecting climate. From this it was immediately evident
that some biological factor must almost certainly be involved in the etiology ofthe
tumor, and the exciting possibility arose that this might be an infectious agent
spread, perhaps, by a climate-dependent arthropod vector. It was therefore decided
to undertake extensive investigations of the Burkitt lymphoma (BL), and biopsy
samples from such tumors were flown from eastern Africa to London and tested in
various ways for the presence ofviruses. Inoculations were made into embryonated
hen eggs, test tissue culture systems, and newborn mice, but these early experiments
proved uniformly negative. Thin sections oftumor samples were therefore searched
in the electron microscope in an effort to find unusual viruses that might not be de-
monstrable by standard isolation procedures, but direct examination oftumor sam-
ples likewise proved negative. It was then considered (5) that success might be
achieved if Burkitt lymphoma cells could be grown in vitro away from host defenses
so that an oncogenic virus might be able to replicate, as happens with cultured cells
from certain virus-induced animal tumors whose causative agent may not be readily
detectable in vivo (6). This concept provided the rationale for the attempted long-
term cultivation of Burkitt lymphoma cells and led directly to the discovery of EB
virus. At the time, however, the prospects for establishing lines of lymphoblastoid
cells from Burkitt tumors were indeed unpromising since no member of the human
lymphoblastic series ofcells had up till then been grown continuously in vitro despite
innumerable efforts ever since theearliest phases ofthe tissue culture technique (7).
However, success was achieved toward the end of 1963 (8); when samples from
the continuously growing Burkitt tumor cells were examined with the electron
microscope, virus particles were observed in a cell within the first grid square to be
searched, and the virus was immediately recognizable morphologically as a typical
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member of the herpes group (1). Although when first seen there was no way of
knowing which herpes virus was present, it soon became clear that the agent was
highly peculiar since it proved biologically inert in the usual test systems (9), and evi-
dence for its immunological uniqueness was soon forthcoming. Antisera to known
herpes viruses did not react in indirect immunofluorescence tests with cells carrying
the virus (10 and 11), while artifical antisera produced in rabbits by injecting purified
EB virus showed that the herpes agents in several different Burkitt tumor cell lines
were immunologically identical and quite distinct from known human herpes viruses
(12 and 13).
New workers in EB virology are sometimes curious as to how the agent first got
its present name. In the early stages considerable help with the establishment of
continuous cultures of Burkitt lymphoblasts was provided by Yvonne Barr, who was
working for a Ph.D. in the laboratory. When the cells eventually grew, they came to
be labeled by the laboratory shorthand of "EB" cells (Epstein/Barr-to distinguish
them from other cells being cultured at the time), and when sent elsewhere as a
source of the virus, the recipients in other laboratories came to designate the virus
itself as EB virus. Shortly after this, Dr. Barr married and exchanged a productive
career in science for a productive career in maternity.
EB VIRUS AS A CANDIDATE HUMAN TUMOR VIRUS
Although EB virus is of general interest as a new herpes virus of man, its main
significance relates to its remarkable association with two human cancers, African
BL and nasopharyngeal carcinoma (NPC). In connection with this association, the
following points have been firmly established and repeatedly confirmed:
1. Authenticated cases of African BL and NPC only occur in individuals
infected by the virus; seroepidemiology has shown that patients with these two tu-
mors have antibodies to the virus, many in high titer, whereas among controls and
patients with other malignancies, seronegatives are found.
2. The viral DNA is present in all the malignant tumor cells and determines the
expression in them of virus coded neoantigens, very much as happens with tumors
known to be caused by animal oncogenic DNA viruses; not surprisingly, at least
with BL, virus production is activated in some of the tumor cells when they are
placed in culture.
3. EB virus is a powerful stimulator oflymphoproliferation in vitro-it confers
the property of continuous growth on human B lymphocytes together with any
changes reminiscent of malignant transformation. Normal human peripheral lym-
phoid cells free of EB virus genome will not grow in tissue culture unless the virus is
added. In contrast, peripheral lymphoid cells from seropositive individuals will grow
continuously in culture since a certain proportion of them already harbor the virus
DNA.
4. The virus is a powerful stimulator of lymphoproliferation in vivo as the
cause ofPaul-Bunnell positive infectious mononucleosis.
5. The virus is carcinogenic experimentally in vivo, causing malignant lym-
phoma when inoculated in South American subhuman primates, in such a manner
that it has been possible to fulfill Koch's postulates with the system.
6. Animal herpesviruses behaving similarly to EB virus are now known to
cause malignant lymphoma or carcinoma in natural or experimental hosts. These
points have all been discussed and fully documented elsewhere (2-4, 14, 15).
Since EB virus occurs as an ubiquitous infection in human populations while the
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tumors with which it is associated have a geographically limited high incidence,
other factors besides EB virus (assuming it actually is carcinogenic) must be in-
volved in causation. It has long been recognized that high incidence areas of BL are
determined by temperature and rainfall (16, 17) and any cofactor would therefore
appear to be environmental; holoendemic malaria has been suggested in this con-
nection (18), and there are cogent reasons for believing that it may provide a suitable
cellular response on which EB virus may then act as a carcinogen. With regard to
NPC, here it has been recognized for some time that genetic cofactors are ofspecial
importance; the disease has a very high incidence only in populations of southern
Chinese origin (19), and among these, certain genetically determined individuals are
unduly at risk (19, 20). However, this cannot be the whole story since the children of
immigrant southern Chinese living in California have a lower incidence ofNPC than
their parents (19).
EB VIRUS INFECTION IN NORMAL INDIVIDUALS
Although the circumstantial evidence incriminating EB virus as an element in the
etiology of BL and NPC is weighty and impressive, many problems remain. A great
deal is known about the behavior of this virus in human populations in which, as al-
ready mentioned, it causes widespread infections (see 21 for review). In contrast,
relatively little is known ofthe biological behavior of EB virus in the infected person,
and this has led to the recognition ofcertain seeming paradoxes.
It has long been known that continuous lymphoblastoid cultures can be readily es-
tablished from biopsy samples of BL and both the lymphoma cells and the cells of
the tumor-derived lines contain EB virus DNA (22 and 23). It is also known from
studies of cytogenetic, IgM specificity, and isoenzyme markers that when lymphoid
lines are obtained from these lymphomas, it is the tumor cells, already malignantly
transformed in vivo, which usually grow out to form the cultures (24-27). On the
other hand, EB virus DNA-containing continuous lymphoblastoid cultures can also
be grown from the peripheral lymphocytes of healthy individuals and patients with
infectious mononucleosis provided that the donors are seropositive (2-4), and this
raises the important question as to the state of the virus in vivo in the few genome-
containing circulating lymphocytes from which these nontumor-derived lines
originate. If EB virus really is an etiological agent in the malignant transformation
underlying BL, can it be present in the tumor cells in the same state as that in which
it infects the peripheral lymphoid cells in the huge number of seropositive people
who do not have lymphomas? In order to elucidate this question, investigations have
recently been undertaken to look at the state of the EB virus genome in the pe-
ripheral lymphoid cells of one group oftumor-free individuals, namely, patients with
IM; the experiments have used cocultures of peripheral lymphoid cells from IM
patients with fetal cord blood lymphoid cells of opposite sex, grown together in mi-
crotest plates by methods which have already been described (28).
In a first set ofexperiments, equal numbers of IM leukocytes and fetal leukocytes
of opposite sex were cocultured and observed for the onset of transformation. The
first cell clumps seen were subcultured, and samples of the resulting cell lines were
taken for chromosome sexing 24 hr after this and after a second subculture, 6-8
days later. Control cultures were set up with IM leukocytes or fetal leukocytes
alone. In these coculture experiments, transformation occurred regularly, and the
resulting transformed cells were made up of mixtures of IM-derived and fetal-
derived cells with a very marked tendency for fetal cells to predominate.
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Transformation did not occur when fetal cells were grown alone, while IM cells
alone gave transformed lines in almost every case. This result suggested that IM cell
lines do not arise in vitro by the direct outgrowth of EB virus genome-containing
cells already transformed in the patient such as occurs with cell lines from biopsies
of Burkitt lymphomas. Instead, something appears to be liberated from IM cells in
culture that brings about the in vitro transformation ofneighboring virus-free cells
from which the lines then derive; the many fetal cells that gave lines in the cocultures
must have been transformed in this way. In a second group ofexperiments, the inci-
dence of transformation was investigated in IM cultures, in fetal cultures from
donors of opposite sex, and in cocultures of X-irradiated IM leukocytes with the
paired fetal cells. The origin of the transformed cells that arose in these cocultures
was determined as before by chromosome sexing. Comparison of the incidence of
transformation in the cultures of IM leukocytes alone with the incidence where IM
leukocytes of similar origin were X-irradiated and grown with fetal leukocytes
showed good correlation, and it was evident that IM patients whose lymphocytes
transformed readily gave ahigh incidence oftransformation when theirlymphocytes
were X-irradiated and cocultured with fetal lymphocytes, and that it was only the
latter that were transformed in such cocultures. This close correlation between the
ability of IM cells from a given donor to transform on their own and their ability
following X-irradiation to transform cocultivated fetal lymphocytes suggests a
similar transformation mechanism in both situations.
Evidence that this transformation mechanism actually depends on the production
of infectious EB virus particles was provided by further experiments in which the
ability ofdifferent samples of IM leukocytes to transform when cultured alone was
found to correlate well with the transforming ability extractable from the samples,
since the extracts could be neutralised by antiserum to EB virus.
This conclusion was studied further in experiments in which the transformation of
IM leucocytes was followed in cultures containing either antiserum to EB virus or
negative serum. The results obtained gave evidence of a different kind, which
confirmed the role of infectious EB virus particles in the emergence of lines of
transformed cells from IM lymphocytes; for where IM cells were cultured at rather
low concentrations in the antiserum, complete abolition of transformation oc-
curred, as compared to cultures in which normal serum was used. This abolition was
shown to be specifically antiviral, not the result of some cytoxic effect of the anti-
serum on transformed cells, since fetal lymphocytes exposed to EB virus and then
immediately cultured in the antiserum showed no cytotoxic effects, and the usual
transformation seen with similarly treated fetal cells grown in negative serum took
place. Theseinvestigations have been described in detail elsewhere (28).
DISCUSSION
The evidence obtained in this work from experiments of several different kinds
clearly shows that continuous cell lines do not arise in vitro from peripheral lym-
phoid cells of patients with IM by the outgrowth of cells already transformed in
vivo, such as occurs with the lymphoid lines ofBurkitt tumor origin. In contrast, the
present results demonstrate that lines arise from IM lymphoid cells by a two-step
mechanism. First, the EB virus genome carried by a small number of peripheral
lymphoid cells is activated to a productive infection with liberation of infectious
virus particles, when the cells are placed in culture. Second, the virus particles infect
nearby normal lymphocytes which then undergo in vitro transformation to give
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lines. In the sparse cultures with little possibility of cell to cell contact, this second
step was completely abolished by antiserum to EB virus. This mechanism is not
thought to be peculiar to the origin of IM-derived lines but is considered to be the
usual process whereby lines arise in vitro from the lymphoid cells ofany seropositive
tumor-free individual. Such people harbor EB virus for life and regularly have a
small number of peripheral lymphoid cells carrying the viral genome, and it would
appear that such cells are merely more numerous during primary infections accom-
panied by the disease manifestations ofIM (29).
The results presented clearly imply that EB virus DNA is present in the peripheral
lymphoid cells of IM patients as a different type ofinfection from that shown by the
virus in the malignantly transformed cells of Burkitt lymphomas; the latter, ma-
lignantly transformed in vivo, grow directly to give tissue culture lines (24-27),
whereas IM lymphocytes depend on virus production to do this in vitro where the
growth of cell lines was inhibited by nontoxic antiserum to EB virus. In this con-
nection, parallel cytogenetic studies on the cells of lymphoblastoid lines of ma-
lignant and nonmalignant origin have demonstrated specific differences in chro-
mosome banding between the two groups (30).
An understanding ofthe various forms ofinfection possible with herpes viruses as
a family readily explains these two different kinds of infection with EB virus in
human lymphoid cells. It has been pointed out elsewhere (21) that besides the
straightforward productive infections caused by herpes viruses with virus replication
leading always to cell death, viruses of this family also exhibit two kinds of non-
productive infection. In one, the virus DNA is unexpressed for long periods but can
be activated to virion production, as happens with herpes simplex virus and
varicella-zoster virus; EB virus in the lymphoid cells of seropositive individuals
seems to follow this pattern. In the other type of nonproductive infection, the viral
genome is expressed to cause malignant transformation with the accompanying
production of viral determined neoantigens, as is seen in the animal lymphomas
caused by herpes virus saimiri (31) and the herpes virus ofMarek's disease (32, 33).
In the context ofour general knowledge of the relationship of EB virus to African
BL and NPC, the results of the experiments discussed here have removed an ap-
parent difficulty in accepting that EB virus might be carcinogenic because they indi-
cate that there seem to be two separate mechanisms for establishing human EB
virus-containing lymphoid cell lines in culture, one relating to tumor cells and the
other to viral genome-containing cells from individuals free of malignant disease.
And this in turn suggests that EB virus causes nonproductive infections without ex-
pression of the viral genome in nonmalignant cells, in contrast to the nonproductive
infections with expression of the genome that appear to occur in the malignant cells
ofAfrican BL and NPC.
If these distinctions are borne in mind, difficulties in accepting EB virus as an
oncogenic agent become apparent rather than real, and the behavior of EB virus in
its various forms of infection is seen to conform exactly to the patterns followed by
other members ofthe herpes virus family.
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